NCT00315692View on ClinicalTrials.gov

Risk of Ovarian Cancer in Patients With a Pelvic Mass

CompletedOBSERVATIONAL
Enrollment

566

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

February 28, 2007

Conditions
Ovarian Cancer
Interventions
DEVICE

Biomarker Assay (CA125 and HE4)

Trial Locations (2)

19355

Fujirebio Diagnostics, Inc, Malvern

02905

Richard Moore, Providence

Sponsors
All Listed Sponsors
lead

Fujirebio Diagnostics, Inc.

INDUSTRY